awards grant
- A...of Saredutant 100 Mg Once Daily in the Prevention of Relapse or Recurrence of Depressive Symptoms in Outpatients...
- Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (Charisma)
- Efc4505: Clopidogrell for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (Charisma)
- Eval of Single-Agent Rasburicase in Treatment/Prevention of Hyperurecemis Assoc W/ Tumor Lysis Syndrome in Adult Patient
- Eval of Single-Agent for 5 Days vs Sequential Treatment W/ Day 1 Through 3 Followed by Oral Allopurinal from Day 3 - 5
- Prospective, Observational Registry and Patient Survey of the Management of Menc Symptomatic Benign Prostatic...
- Randomized Multi-Center 2-Blnd Placebo-Ctrl 2-Arm Pllel Grp Trial of Rimonabant 20-Mg for Inhib of Atherosclerosis Progression...
- Randomized, Multinational, Multicenter, Double-Blind, Placebo-Controlled, Two Arm Parallel Group Trial of Rimonabant 20
- Randomized, Multinational, Multicenter, Double-Blind, Placebo-Controlled, Two Arm Parallel Group Trial of Rimonabant 20
- Role of Uric Acid in Acute Renal Failure
- Satavaptan in the Prevention of Ascites Recurrence: a double-blind, randomized, parallel-group comparison of satavaptan at 5 to 10 mg daily versus placebo with concomitant diuretics in patients with recurrent ascites due to cirrhosis of the liver